Phase 2 Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML."
2d agoen
From the article
Conditions : Leukemia, Myeloid, Acute Interventions : Drug: Revumenib; Drug: Fludarabine; Drug: Cytarabine (Ara-C); Drug: Methotrexate (IT); Drug: Hydrocortisone (intrathecal); Drug: Cytarabine (intrathecal) Sponsors : Therapeutic Advances in Childhood Leukemia Consortium Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
CCR study reveals how leukemia chemotherapy drug Ara-C damages neurons causing balance problems
CCR scientists led by Andre Nussenzweig have discovered why the chemotherapy drug Ara-C (used to treat blood cancers) causes movement and ba
go.nih.gov·15d ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·3d ago
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer | NEJM
nejm.org·1mo ago
Study reveals resistance mechanisms and potential treatment strategy for anaplastic thyroid cancer using type II RAF inhibitors
This study investigates resistance mechanisms to MAPK inhibition in anaplastic thyroid cancer (ATC), a highly lethal cancer. Using multi-reg
cell.com·18d ago
Targeting genomic instability: From chemotherapy to precision medicine in cancer treatment
This article examines genomic instability as a hallmark of cancer, explaining how it drives malignant transformation through accumulated gen
cell.com·25d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.